Rankings
▼
Calendar
BEAM (Beam Therapeutics Inc.) Stock Financials & Earnings | Market Cap Arena
BEAM
Beam Therapeutics Inc.
Mkt Cap
$3B
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$140M
Net Income (TTM)
-$80M
EPS (TTM)
-$1.01
Free Cash Flow (TTM)
-$360M
Gross Margin
-126.1%
Op. Margin
-274.6%
Net Margin
-57.2%
FCF Margin
-257.7%
P/S Ratio (TTM)
20.0x
P/E Ratio (TTM)
—
YoY Rev Growth
+120.0%
Employees
—
Earnings Reports
▶
Q4 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$24M
-$75M
-$99M
Q2 23
$20M
-$77M
-$102M
Q3 23
$17M
-$83M
-$108M
Q4 23
$316M
$176M
$133M
Q1 24
$7M
-$77M
-$104M
Q2 24
$12M
$12M
-$105M
Q3 24
$14M
-$80M
-$107M
Q4 24
$30M
-$71M
-$100M
Q1 25
$7M
-$91M
-$119M
Q2 25
$8M
-$93M
-$120M
Q3 25
$10M
-$100M
-$127M
Q4 25
$114M
$108M
-$17M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
36.4x
—
Q2 23
34.8x
—
Q3 23
34.2x
—
Q4 23
7.4x
—
Q1 24
7.7x
—
Q2 24
7.9x
—
Q3 24
8.0x
—
Q4 24
43.9x
—
Q1 25
43.9x
—
Q2 25
46.3x
—
Q3 25
50.1x
—
Q4 25
20.0x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$110M
-$116M
Q2 23
-$85M
-$101M
Q3 23
-$90M
-$98M
Q4 23
$135M
$131M
Q1 24
-$100M
-$102M
Q2 24
-$83M
-$85M
Q3 24
-$88M
-$90M
Q4 24
-$76M
-$79M
Q1 25
-$104M
-$107M
Q2 25
-$76M
-$80M
Q3 25
-$81M
-$86M
Q4 25
-$83M
-$87M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$6M
Q2 23
$16M
Q3 23
$8M
Q4 23
$4M
Q1 24
$2M
Q2 24
$2M
Q3 24
$2M
Q4 24
$3M
Q1 25
$3M
Q2 25
$3M
Q3 25
$5M
Q4 25
$4M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+187.1%
+45.5%
Q2 23
+20.8%
+24.0%
Q3 23
+8.8%
+17.1%
Q4 23
+1478.0%
+68.2%
Q1 24
-69.4%
-9.4%
Q2 24
-41.5%
-4.6%
Q3 24
-17.0%
-3.7%
Q4 24
-90.5%
-29.0%
Q1 25
+0.8%
+13.6%
Q2 25
-28.1%
+10.2%
Q3 25
-32.0%
+13.0%
Q4 25
+279.5%
+1.1%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$24M
98.8%
Q2 23
$26M
130.6%
Q3 23
$26M
150.3%
Q4 23
$23M
7.2%
Q1 24
$29M
395.2%
Q2 24
$32M
268.5%
Q3 24
$30M
207.2%
Q4 24
$30M
100.5%
Q1 25
$27M
357.2%
Q2 25
$24M
287.8%
Q3 25
$23M
234.6%
Q4 25
-$74M
-64.7%
marketcaparena.com
OpEx Breakdown
R&D
G&A
Quarter
R&D
G&A
Q1 23
$100M
$23M
Q2 23
$98M
$25M
Q3 23
$100M
$25M
Q4 23
$140M
$43M
Q1 24
$85M
$27M
Q2 24
$87M
$30M
Q3 24
$94M
$27M
Q4 24
$101M
$29M
Q1 25
$99M
$28M
Q2 25
$102M
$27M
Q3 25
$110M
$27M
Q4 25
$99M
$27M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$250M
$810M
$1.1B
Q2 23
$226M
$847M
$1.1B
Q3 23
$169M
$846M
$1.0B
Q4 23
$436M
$754M
$1.2B
Q1 24
$288M
$807M
$1.1B
Q2 24
$293M
$715M
$1.0B
Q3 24
$230M
$696M
$926M
Q4 24
$282M
$569M
$851M
Q1 25
$528M
$692M
$1.2B
Q2 25
$282M
$868M
$1.2B
Q3 25
$268M
$807M
$1.1B
Q4 25
$295M
$950M
$1.2B
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
72M
+2.1%
Q2 23
76M
+5.6%
Q3 23
79M
+3.5%
Q4 23
83M
+4.7%
Q1 24
82M
-1.2%
Q2 24
82M
+0.8%
Q3 24
82M
+0.1%
Q4 24
83M
+0.5%
Q1 25
88M
+6.2%
Q2 25
102M
+15.9%
Q3 25
103M
+0.6%
Q4 25
105M
+2.3%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 17
—
—
FY 18
—
—
FY 19
$153
118
FY 20
$133
181
FY 21
$864
60K
FY 22
$1K
60K
FY 23
$4K
100K
FY 24
$635
100K
FY 25
$1K
100K
marketcaparena.com